WHO ICTRP trial

Efficacy and safety of Enzymatic Hydrolysate of Skipjack Tuna Cooking Drip on…

KCT0002207 · Clinical Research Information Service (CRIS) · Not Recruiting

Key facts

Trial ID KCT0002207
Public title Efficacy and safety of Enzymatic Hydrolysate of Skipjack Tuna Cooking Drip on reducing body weight and body fat in overweight subjects; A 12week, Randomized, Double-blind, Placebo-Controlled Clinical Trial
Scientific title Efficacy and safety of Enzymatic Hydrolysate of Skipjack Tuna Cooking Drip on reducing body weight and body fat in overweight subjects; A 12week, Randomized, Double-blind, Placebo-Controlled Clinical Trial
Primary sponsor Pukyung National University
Registry Clinical Research Information Service (CRIS)
Recruitment status Not Recruiting
Study type Interventional Study
Phase Not applicable
Countries Korea, Republic of
Conditions Endocrine, nutritional and metabolic disease
Interventions Dietary Supplement : Subjects will be randomized to receive Enzymatic Hydrolysate of Skipjack Tuna Cooking Drip 1g or placebo. Subjects will orally self-adminster BST898 or placebo bid, 1cap per day for 12weeks.
Registration date Feb 1, 2017
Target size 80
Registry page cris.nih.go.kr

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations